United States: Lingering In Lexmark's Wake, Uncertainty About The Limits Of Patent Exhaustion


According to ten judges of the Federal Circuit, a patent owner's right to sue for infringement in the United States is not exhausted by sales of products abroad or by sales subject to valid post-sale contractual restrictions on use. See Lexmark Int'l, Inc. v. Impression Prods, Inc., Nos. 2014-1617, slip op. (Fed. Cir. Feb. 12, 2016). In a 10-2 en banc decision which affirmed in part and reversed in part the lower court's decision, the Circuit court held that U.S. patent rights need not be expressly reserved in foreign sales transactions to preserve the right to sue for infringement if the goods enter the United States downstream of the point of sale. The court further held that patent holders can enforce—under patent law—post-sale use restrictions imposed at the point of first sale not only against the buyer under contract law, but also against the buyer or a subsequent third party purchaser. A dissenting opinion authored by Judge Timothy Dyk and joined by Judge Hughes strongly disagreed with the majority's opinion on both issues, cautioning that the majority's decision cannot be reconciled with prior Supreme Court case law, sharply adding that "[w]e exceed our role as a subordinate court by declining to follow the explicit domestic exhaustion rule announced by the Supreme Court." Lexmark Int'l, at __ (dissenting opinion) (slip op. at 2).1The dissent also urged that presumptive exhaustion should apply to foreign sales, exhausting patent rights where those rights are not expressly reserved.

Facts and Procedural Posture

Lexmark makes and sells printers and cartridges, and owns patents that cover its cartridges and their use. It is undisputed that the cartridges at issue were first sold by Lexmark, some abroad and some in the United States. The domestic cartridges at issue were sold at a discounted price but encumbered by a single-use/no-resale restriction at the point of sale. Impression Products is a reseller of Lexmark cartridges. Impression acquired both foreign-sold cartridges and restricted use domestic cartridges after a third party modified those cartridges in violation of the single-use/no-resale restriction and sold them to third parties. Lexmark sued Impression for patent infringement under 35 U.S.C. §§ 271(a) and (c).

Impression responded to Lexmark's infringement suit with two motions to dismiss, arguing that although the cartridges it sells are covered by Lexmark's patents, and those patents are valid, Lexmark's right to sue is exhausted by Lexmark's initial sale of the goods. The district court granted Impression's motion to dismiss as to its sales of Lexmark's cartridges that were sold in the United States, finding that Quanta overruled Mallinckrodt, and that post-sale restrictions did not prevent Lexmark's patent rights from exhaustion after the first authorized sale of the cartridges. However, the district court found that patent exhaustion did not apply to Lexmark's cartridges sold abroad because, it found, the Supreme Court's copyright law decision in Kirtsaeng did not overrule the Federal Circuit's patent law decision Jazz Photo. Following the district court's decision, the parties entered into a Stipulated Final Judgment under 28 U.S.C. § 1295(a)(1) in favor of Impression as to cartridges sold in the United States and in favor of Lexmark as to cartridges sold abroad. After oral argument before a panel of three circuit judges, the Federal Circuit issued an order sua sponte taking the case en banc.

What Is Patent Exhaustion?

Patent exhaustion is an affirmative defense that acts as a limit on the patent owner's statutory right to control what purchasers can do with an article embodying or containing a patented invention after its first authorized sale. Simply put, once a patented good is sold with the permission of a patent owner, no suit for infringement can be brought as to that article's use or re-sale. The basic doctrine of patent exhaustion has been available as a defense since at least the mid-19th century, but has evolved over time to encompass the sale of incomplete articles that "substantially embody" a patented method or apparatus.

Why is Lexmark So Controversial?

Lexmark has significant consequences for licensing agreements and international trade. The Federal Circuit received over thirty amicus curiae briefs on the en banc issue, in addition to those of the parties and the United States Government. The court's diverse amici included industry organizations such as Pharmaceutical Research and Manufacturers of America, Biotechnology Industry Organization, Electronic Frontier Foundation, and Computer and Communications Industry Association, as well as industry giants themselves like LG Electronics, Google, Intel, and Costco, and influential academics and bar associations.

One reason for the exceptional interest in this case is that although patent exhaustion is not a new doctrine, there is relatively little modern case law deciding its limits. Indeed, both the majority and dissenting opinions primarily rely on case law dating back to the mid-19th and early-20th centuries. The resulting opinion strikes at the heart of differences between property and contract law, with the law of property counseling against post-sale restrictions on validly conveyed chattels, and the law of contract permitting owners to freely set the terms of sale. Lexmark's scholarly 122-page opinion belies the fact that the decision came down to two simple questions that are at the center of the dispute as applied in the patent exhaustion context: First, what is the meaning of "authorized sale" in the patent exhaustion context, and what impact does that have on use "without authority" in the context of 35 U.S.C. § 271(a)? Second, what is an "unconditional" sale?

On the first question, the majority holds that an article is used "without authority" in violation of 35 U.S.C. § 271(a) if a particular use is expressly prohibited by contractual terms imposed at the time of initial sale. Crucially, the majority's view extends to uses by a downstream purchaser even though the downstream purchaser is not a party to the initial transaction or even aware of the conditions imposed therein. In contrast, the dissent's view is that "authority" turns not on whether the buyer had authority to use the purchased article in a particular way, but whether the seller had authority to sell it. According to the dissent, once a first sale is made by a party that has the full right and power to make the sale, Section 271(a) cannot be invoked to recover under the patent laws, leaving breach of contract as the sole remedy available to the patent owner. In other words, the dissent would hold that no action subsequent to an authorized sale can vitiate the initial "authority" conferred by the transfer of title itself.

On the second question of conditional sales, the majority and dissent again approach the question from two very different perspectives. The majority's view is that an "unconditional" sale is one made without contractual restrictions on the post-sale use of the sold article. For example, per the majority, a sale is conditional if the relevant sale places use or sale restrictions on the first purchaser. An arguable implication of the majority's view is that contractual terms agreed to by the seller and first purchaser place a de facto encumbrance on the article, such that any downstream purchaser remains bound by the restrictions agreed to in the first sale. In contrast, the dissent states that an "unconditional" sale simply means that full title in the article is conveyed in the purchaser at the time of sale. The dissent explains that a sale is conditional as a matter of property law if, for example, the seller retains title until the buyer has paid the full purchase price. However, per the dissent, once title passes to a buyer the sale is at that point "unconditional," irrespective of any contractual restrictions on use. The dissent would hold that although post-sale conditions may be valid and enforceable in contract, they are not enforceable as a matter of patent law.

The majority and dissent thus depart not just as to the result, but on the very ground patent exhaustion stands on. As to domestic sales with restrictions, the split implicates the first principles of property and contract law—i.e., whether contracting parties can impose post-sale restrictions on personal property that run with the property itself and bind third parties—lending Lexmark a significance that threatens to redefine patent law's place in the common law landscape. As to foreign sales, the split likewise raises important questions regarding harmonizing patent law with general common law and copyright principles. Of more prosaic concern, the majority and dissent disagree as to whether the Supreme Court's Quanta and Kirtsaeng decisions overruled their corresponding Federal Circuit decisions. Lexmark fails to give litigants a clear path forward, and may leave parties tempted to continue citing Supreme Court precedent until greater clarity on the precise limits of patent exhaustion is given.

The consequences of uncertainty in Lexmark's wake are significant. Both the majority and dissent spend large portions of their opinions discussing the policy implications of their respective conclusions.

Lexmark's Immediate Implications

Lexmark holds that patent owners wanting to retain the ability to sue downstream consumers for patent infringement after an initial sale of an article for use of said article can do so by placing contractual conditions on the article at the point of first sale. Nevertheless, the Lexmark rule is precariously situated at the moment and likely to be reviewed by the Supreme Court. Patent owners should proceed with caution when selling patented articles to purchasers who are either (a) likely to violate the terms of a sale agreement with post-sale restrictions; or (b) would be effectively judgment-proof in a breach of contract proceeding for financial reasons. On the downstream purchaser side, companies that acquire and resell potentially patented items risk substantial liability for patent infringement, and may be well-served to acquire authorization for their activities from patent owners directly. At the very least, such purchasers must take seriously any threatened litigation by patent owners who claim that the purchaser's activities are unauthorized. In addition—and in contrast to copyright law—patentees may find comfort in knowing that patent law has territorial limits under which patentees need not expressly reserve rights in the United States in their foreign transactions. However, this holding is also strongly opposed, and patent owners may be well served to reserve rights in foreign transactions whenever practicable. Importers should not assume freedom to operate under patent law when purchasing articles initially sold abroad.

Going forward, all affected parties should be cautious in implementing any strategies based on the current law as set forth in Lexmark. The strength of the opposition to the Lexmark rule is likely to fuel Supreme Court review. Indeed, Lexmark's rule—which strongly favors patentee's rights—may prove difficult to administer. As amici LG Electronics, Inc., Dell Inc., Google Inc., Intel Inc., et al. wrote in their brief in support of Impression, "modern devices include components from dozens—if not hundreds—of suppliers," and a manufacturer may now be required to "trace the patent rights of every component it purchases and then negotiate appropriate license arrangements" with any manufacturer and sub-manufacturer. Similarly, Costco expressed concern in its amicus brief that it routinely sells genuine goods that were not purchased from the patentee, some of which were first sold abroad. On the other hand, the policy considerations at play in Lexmark are complicated and cut both ways. Biotechnology, medical device, and pharmaceutical industry companies generally favor the Lexmark rule because it preserves their ability to implement price discrimination strategies in both domestic and foreign sales, which in turn enables them to disseminate their technology across a broader swath of consumers including those who do not want, and cannot afford, the full bundle of "make, use, offer to sell or sell" rights granted under the patent.

Likelihood of Supreme Court Granting Certiorari

In light of the issues raised by Lexmark—and in particular the split over whether two Supreme Court decisions overrule two earlier Federal Circuit decisions—Supreme Court review of Lexmark is likely. Should the Court fail to grant certiorari, litigants can expect continued uncertainty regarding the applicability of patent exhaustion where sales are subject to contractual restrictions or where goods were sold for the first time abroad without express reservation of rights in the United States.


Although the Federal Circuit's decision purports to maintain the status quo regarding patent exhaustion, Lexmark has immediate implications for patentees, licensees, and downstream consumers alike. The dissent's treatment of Quanta and Kirtsaeng shows that patent exhaustion remains controversial, and the Supreme Court is likely to review Lexmark. In the absence of a clear articulation of the patent exhaustion rule following Supreme Court review, we can expect uncertainty regarding the patent exhaustion rule's application to contractually restricted and foreign sales to persist.


1. The majority found that Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008)did not overrule Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700 (Fed. Cir. 1992), and that Kirtsaeng v. John Wiley & Sons, Inc., 133 S. Ct. 1351 (2013)—a copyright decision—did not overrule Jazz Photo Corp. v. International Trade Comm'n, 264 F.3d 1094 (Fed. Cir. 2001).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
20 Sep 2018, Other, California, United States

CoinAlts is designed to bring together the thought leaders in the cryptocurrency investment space to discuss the investment, legal and operational is​sues for cryptocurrencies as a new asset class.

25 Sep 2018, Conference, California, United States

We're excited to introduce Women's IP Strategy, a 2-day conference that tackles both the IP, legal as well as broader career development obstacles, risks and rewards for women lawyers working in male-dominant industries.

2 Oct 2018, Webinar, California, United States

This CLE webinar will offer suggestions to litigators to help them comply with the new GDPR during e-discovery.

Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions